Skip to main content
Top
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Myasthenia Gravis | Research

Hemogram parameters can predict in-hospital mortality of patients with Myasthenic crisis

Authors: Che-Wei Hsu, Nai-Ching Chen, Wei-Chin Huang, Hui-Chen Lin, Wan-Chen Tsai, Chih-Cheng Huang, Ben-Chung Cheng, Nai-Wen Tsai

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

Myasthenia gravis (MG) is an autoimmune disease involving the neuromuscular junction. Myasthenic crisis (MC), which is characterized by respiratory failure and the requirement of mechanical ventilation in patients with MG, is still a medical emergency despite the decrease in mortality with the advances in acute management. Hemogram is a cost-effective test for evaluating hematological complications and systemic inflammation, and hemogram data have been used to predict various clinical outcomes of several diseases. The relationship between hemogram and MG has been discussed, but the role of hemogram data in predicting the prognosis of MC patients has not been established.

Methods

To identify whether hemogram data can predict in-hospital mortality in patients with MC, we retrospectively investigated 188 myasthenic crisis events from the Chang Gung Research Database between April 2001 and March 2019. Demographic and clinical characteristics were collected, as well as hemogram data before intubation and extubation. The endpoints were mortality during mechanical ventilation and mortality after extubation.

Results

The overall in-hospital mortality rate was 22%. Multivariate logistic regression analysis for predicting mortality during mechanical ventilation showed that old age at MC onset (OR = 1.039, p = 0.022), moderate-to-severe anemia (OR = 5.851, p = 0.001), and extreme leukocytosis (OR = 5.659, p = 0.022) before intubation were strong predictors of mortality, while acute management with plasma exchange or double-filtration plasmapheresis (PE/DFPP) significantly decreased mortality (OR = 0.236, p = 0.012). For predicting mortality after extubation, moderate-to-severe anemia before extubation (OR = 8.452, p = 0.017) and non-treated with disease-modifying therapy before MC (OR = 5.459, p = 0.031) were crucial predictive factors.

Conclusion

This study demonstrated that both old age at MC onset and moderate-to-severe anemia are important predictors of in-hospital mortality in patients with MC, and extreme leukocytosis is another crucial predictor of mortality during mechanical ventilation. The suggested mechanism is that anemia-induced hypoxia may enhance the release of proinflammatory cytokines, exacerbate systemic inflammation, and lead to multiple organ dysfunction syndrome and, finally, mortality.
Literature
1.
go back to reference Gilhus NE, Socrates T, Amelia E, Jacqueline P, Burns TM. Myasthenia gravis (primer). Nat Rev Dis Primers. 2019;5:1.CrossRef Gilhus NE, Socrates T, Amelia E, Jacqueline P, Burns TM. Myasthenia gravis (primer). Nat Rev Dis Primers. 2019;5:1.CrossRef
6.
go back to reference Lawrence Y, Raveh D, Rudensky B, Munter G. Extreme leukocytosis in the emergency department. J Assoc Phys. 2007;100(4):217–23. Lawrence Y, Raveh D, Rudensky B, Munter G. Extreme leukocytosis in the emergency department. J Assoc Phys. 2007;100(4):217–23.
7.
go back to reference Bedlack RS, Sanders DB. On the concept of myasthenic crisis. J Clin Neuromuscul Dis. 2002;4(1):40–2.CrossRef Bedlack RS, Sanders DB. On the concept of myasthenic crisis. J Clin Neuromuscul Dis. 2002;4(1):40–2.CrossRef
8.
go back to reference Cohen MS, Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann N Y Acad Sci. 1981;377(1):670–7.CrossRef Cohen MS, Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann N Y Acad Sci. 1981;377(1):670–7.CrossRef
9.
go back to reference Alshekhlee A, Miles J, Katirji B, Preston D, Kaminski H. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology. 2009;72(18):1548–54.CrossRef Alshekhlee A, Miles J, Katirji B, Preston D, Kaminski H. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology. 2009;72(18):1548–54.CrossRef
11.
go back to reference Cortés-Vicente E, Gallardo E, Álvarez-Velasco R, Illa I. Myasthenia gravis treatment updates. Curr Treat Options Neurol. 2020;22(8):1–14.CrossRef Cortés-Vicente E, Gallardo E, Álvarez-Velasco R, Illa I. Myasthenia gravis treatment updates. Curr Treat Options Neurol. 2020;22(8):1–14.CrossRef
12.
go back to reference Köhler W, Bucka C, Klingel R. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis. J Clin Apher. 2011;26(6):347–55.CrossRef Köhler W, Bucka C, Klingel R. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis. J Clin Apher. 2011;26(6):347–55.CrossRef
14.
go back to reference Munro N. Hematologic complications of critical illness: anemia, neutropenia, thrombocytopenia, and more. AACN Adv Crit Care. 2009;20(2):145–54.PubMed Munro N. Hematologic complications of critical illness: anemia, neutropenia, thrombocytopenia, and more. AACN Adv Crit Care. 2009;20(2):145–54.PubMed
15.
go back to reference Menon V, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol. 2003;92(4):368–72.CrossRef Menon V, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol. 2003;92(4):368–72.CrossRef
16.
go back to reference Shu DH, Ransom TP, O'Connell CM, Cox JL, Kaiser SM, Gee SA, et al. Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes. Cardiovasc Diabetol. 2006;5(1):1–9.CrossRef Shu DH, Ransom TP, O'Connell CM, Cox JL, Kaiser SM, Gee SA, et al. Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes. Cardiovasc Diabetol. 2006;5(1):1–9.CrossRef
17.
go back to reference Sy RW, Chawantanpipat C, Richmond DR, Kritharides L. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol. 2008;51(18):1824–5.CrossRef Sy RW, Chawantanpipat C, Richmond DR, Kritharides L. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol. 2008;51(18):1824–5.CrossRef
19.
go back to reference Martinez-Rivera C, Portillo K, Muñoz-Ferrer A, Martínez-Ortiz ML, Molins E, Serra P, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD: J Chron Obstruct Pulmon Dis. 2012;9(3):243–50.CrossRef Martinez-Rivera C, Portillo K, Muñoz-Ferrer A, Martínez-Ortiz ML, Molins E, Serra P, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD: J Chron Obstruct Pulmon Dis. 2012;9(3):243–50.CrossRef
20.
go back to reference Hu SL, Said FR, Epstein D, Lokeshwari M. The impact of anemia on renal recovery and survival in acute kidney injury. Clin Nephrol. 2013;79(3):221–8.CrossRef Hu SL, Said FR, Epstein D, Lokeshwari M. The impact of anemia on renal recovery and survival in acute kidney injury. Clin Nephrol. 2013;79(3):221–8.CrossRef
21.
go back to reference Hao Z, Wu B, Wang D, Lin S, Tao W, Liu M. A cohort study of patients with anemia on admission and fatality after acute ischemic stroke. J Clin Neurosci. 2013;20(1):37–42.CrossRef Hao Z, Wu B, Wang D, Lin S, Tao W, Liu M. A cohort study of patients with anemia on admission and fatality after acute ischemic stroke. J Clin Neurosci. 2013;20(1):37–42.CrossRef
22.
go back to reference Reade MC, Weissfeld L, Angus DC, Kellum JA, Milbrandt EB. The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulmon Med. 2010;10(1):1–10.CrossRef Reade MC, Weissfeld L, Angus DC, Kellum JA, Milbrandt EB. The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulmon Med. 2010;10(1):1–10.CrossRef
24.
go back to reference Gunaldi M, Goksu S, Erdem D, Gunduz S, Okuturlar Y, Tiken E, et al. Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study. Int J Clin Exp Med. 2015;4:5937. Gunaldi M, Goksu S, Erdem D, Gunduz S, Okuturlar Y, Tiken E, et al. Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study. Int J Clin Exp Med. 2015;4:5937.
26.
27.
go back to reference Yang D-H, Qian M-Z, Wei M-M, Li J, Yu M-M, Lu X-M, et al. The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis. Oncotarget. 2017;44:76099.CrossRef Yang D-H, Qian M-Z, Wei M-M, Li J, Yu M-M, Lu X-M, et al. The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis. Oncotarget. 2017;44:76099.CrossRef
29.
go back to reference Organization WH. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity: World Health Organization; 2011. Organization WH. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity: World Health Organization; 2011.
31.
go back to reference Khurana D, Deoke SA. Thrombocytopenia in critically ill patients: clinical and laboratorial behavior and its correlation with short-term outcome during hospitalization. Indian J Crit Care Med. 2017;12:861.CrossRef Khurana D, Deoke SA. Thrombocytopenia in critically ill patients: clinical and laboratorial behavior and its correlation with short-term outcome during hospitalization. Indian J Crit Care Med. 2017;12:861.CrossRef
32.
go back to reference Lv Z, Zhong H, Huan X, Song J, Yan C, Zhou L, et al. Predictive score for in-hospital mortality of Myasthenic crisis: a retrospective Chinese cohort study. Eur Neurol. 2019;81(5-6):287–93.CrossRef Lv Z, Zhong H, Huan X, Song J, Yan C, Zhou L, et al. Predictive score for in-hospital mortality of Myasthenic crisis: a retrospective Chinese cohort study. Eur Neurol. 2019;81(5-6):287–93.CrossRef
34.
go back to reference Roper J, Fleming ME, Long B, Koyfman A. Myasthenia gravis and crisis: evaluation and management in the emergency department. J Emerg Med. 2017;53(6):843–53.CrossRef Roper J, Fleming ME, Long B, Koyfman A. Myasthenia gravis and crisis: evaluation and management in the emergency department. J Emerg Med. 2017;53(6):843–53.CrossRef
35.
go back to reference Werneck LC, Scola RH, Germiniani FMB, Comerlato EA, Cunha FMB. Myasthenic crisis: report of 24 cases. Arq Neuropsiquiatr. 2002;60(3A):519–26.CrossRef Werneck LC, Scola RH, Germiniani FMB, Comerlato EA, Cunha FMB. Myasthenic crisis: report of 24 cases. Arq Neuropsiquiatr. 2002;60(3A):519–26.CrossRef
36.
go back to reference Sharma S, Lal V, Prabhakar S, Agarwal R. Clinical profile and outcome of myasthenic crisis in a tertiary care hospital: a prospective study. Ann Indian Acad Neurol. 2013;16(2):203.CrossRef Sharma S, Lal V, Prabhakar S, Agarwal R. Clinical profile and outcome of myasthenic crisis in a tertiary care hospital: a prospective study. Ann Indian Acad Neurol. 2013;16(2):203.CrossRef
37.
go back to reference Lee C, Lam C, Pang S, Lau K, Teo K, Chang R, et al. Clinical outcome of generalized myasthenia gravis in Hong Kong Chinese. J Neuroimmunol. 2015;289:177–81.CrossRef Lee C, Lam C, Pang S, Lau K, Teo K, Chang R, et al. Clinical outcome of generalized myasthenia gravis in Hong Kong Chinese. J Neuroimmunol. 2015;289:177–81.CrossRef
38.
go back to reference Gilhus NE, Romi F, Hong Y, Skeie GO. Myasthenia gravis and infectious disease. J Neurol. 2018;265(6):1251–8.CrossRef Gilhus NE, Romi F, Hong Y, Skeie GO. Myasthenia gravis and infectious disease. J Neurol. 2018;265(6):1251–8.CrossRef
39.
go back to reference Donaldson D, Ansher M, Horan S, Rutherford R, Ringel S. The relationship of age to outcome in myasthenia gravis. Neurology. 1990;40(5):786.CrossRef Donaldson D, Ansher M, Horan S, Rutherford R, Ringel S. The relationship of age to outcome in myasthenia gravis. Neurology. 1990;40(5):786.CrossRef
41.
go back to reference Waheed U, Williams P, Brett S, Baldock G, Soni N. White cell count and intensive care unit outcome. Anaesthesia. 2003;58(2):180–2.CrossRef Waheed U, Williams P, Brett S, Baldock G, Soni N. White cell count and intensive care unit outcome. Anaesthesia. 2003;58(2):180–2.CrossRef
42.
go back to reference Thomas C, Mayer S, Gungor Y, Swarup R, Webster E, Chang I, et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology. 1997;48(5):1253–60.CrossRef Thomas C, Mayer S, Gungor Y, Swarup R, Webster E, Chang I, et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology. 1997;48(5):1253–60.CrossRef
43.
go back to reference Liu X-D, Shao M-R, Sun L, Zhang L, Jia X-S, Li W-Y. Influence of body mass index on postoperative complications after thymectomy in myasthenia gravis patients. Oncotarget. 2017;8(55):94944.CrossRef Liu X-D, Shao M-R, Sun L, Zhang L, Jia X-S, Li W-Y. Influence of body mass index on postoperative complications after thymectomy in myasthenia gravis patients. Oncotarget. 2017;8(55):94944.CrossRef
44.
go back to reference Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364(7):656–65.CrossRef Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364(7):656–65.CrossRef
45.
go back to reference Sabit R, Thomas P, Shale DJ, Collins P, Linnane SJ. The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest. 2010;138(1):47–51.CrossRef Sabit R, Thomas P, Shale DJ, Collins P, Linnane SJ. The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest. 2010;138(1):47–51.CrossRef
46.
go back to reference Xu X-M, Yao D, Cai X-D, Ding C, Lin Q-D, Wang L-X, et al. Effect of chronic continual-and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats. Sleep Breath. 2015;19(2):677–84.CrossRef Xu X-M, Yao D, Cai X-D, Ding C, Lin Q-D, Wang L-X, et al. Effect of chronic continual-and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats. Sleep Breath. 2015;19(2):677–84.CrossRef
47.
go back to reference Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine. 1991;3(3):189–94.CrossRef Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine. 1991;3(3):189–94.CrossRef
48.
go back to reference Naldini A, Carraro F, Silvestri S, Bocci V. Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells. J Cell Physiol. 1997;173(3):335–42.CrossRef Naldini A, Carraro F, Silvestri S, Bocci V. Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells. J Cell Physiol. 1997;173(3):335–42.CrossRef
49.
go back to reference Kiers HD, Scheffer G-J, van der Hoeven JG, Eltzschig HK, Pickkers P, Kox M. Immunologic consequences of hypoxia during critical illness. Anesthesiology. 2016;125(1):237–49.CrossRef Kiers HD, Scheffer G-J, van der Hoeven JG, Eltzschig HK, Pickkers P, Kox M. Immunologic consequences of hypoxia during critical illness. Anesthesiology. 2016;125(1):237–49.CrossRef
50.
go back to reference Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 2001;29(7):S99–S106.CrossRef Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 2001;29(7):S99–S106.CrossRef
Metadata
Title
Hemogram parameters can predict in-hospital mortality of patients with Myasthenic crisis
Authors
Che-Wei Hsu
Nai-Ching Chen
Wei-Chin Huang
Hui-Chen Lin
Wan-Chen Tsai
Chih-Cheng Huang
Ben-Chung Cheng
Nai-Wen Tsai
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02412-4

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue